This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Lisinopril 40 mg tablets in quantities of 1,000 to the U.S. government. The contract, valued at $3,503.44, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for 4,563,574,760 units of the pharmaceutical product Lisinopril 40 mg tablets, with a potential value of $8,392.26 and a completion date of February 7, 2024. This contract is not designated as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides Lisinopril 40 mg tablets to the Defense Logistics Agency (DLA) for $3,076.92. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora to deliver a wide range of pharmaceutical products and medical...
This is a federal contract award valued at $7,856.00 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of 1,000 units of the medication Lisinopril-HCTZ 10-12.5 mg tablets. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets, a pharmaceutical product used to treat high blood pressure. The contract has a total ceiling value of $2,492.03 and is structured as a Firm Fixed Price Delivery Order, with an ultimate completion date of April 19, 2024. Amerisourcebergen holds a larger Indefinite...
This contract is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract has a potential value of $4,096.00 and a completion date of February 20, 2024. The contract provides for the delivery of 1,000 units of the pharmaceutical product Lisinopril 40 mg tablets to support U.S. Department of Defense medical treatment programs and facilities. No set-aside designation is mentioned....
This federal contract award is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count sizes. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,836.11, is for the delivery of 1,000 tablets of lisinopril-HCTZ 20-12.5 mg, a medication used to treat high blood pressure. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
This federal contract award, SPE2DB24D1205|SPE2DB24FCSGH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,080.66 firm fixed-price delivery order is for the supply of 4,564,996,750 units of the drug Lisinopril, a medication used to treat high blood pressure and heart failure. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...